Zoe M. Weinstein, MD, MS

Assistant Professor, Medicine

Zoe Weinstein
617.414.7399
801 Massachusetts Ave Crosstown Center

Biography

Zoe M. Weinstein MD,MS, is a general internist and a graduate of the Boston University Addiction Medicine Fellowship. Her research interests include the health of urban underserved patients, especially in the areas of addiction and HIV. Her current clinical work and research are focused on long-term Office-Based Opioid Treatment (OBOT) with buprenorphine, the integration of addiction treatment with primary care and inpatient medical care. She is currently the director of Boston Medical Center’s Addiction Consult Service.

Education

  • University of California San Francisco, MD
  • Columbia University, BA

Publications

  • Published on 6/20/2019

    Kathuria H, Seibert RG, Cobb V, Weinstein ZM, Gowarty M, Helm ED, Wiener RS. Patient and Physician Perspectives on Treating Tobacco Dependence in Hospitalized Smokers With Substance Use Disorders: A Mixed Methods Study. J Addict Med. 2019 Jun 20. PMID: 31232740.

    Read at: PubMed
  • Published on 5/3/2019

    Morgan JR, Schackman BR, Weinstein ZM, Walley AY, Linas BP. Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort. Drug Alcohol Depend. 2019 Jul 01; 200:34-39. PMID: 31082666.

    Read at: PubMed
  • Published on 2/19/2019

    McNeely J, Troxel AB, Kunins HV, Shelley D, Lee JD, Walley A, Weinstein ZM, Billings J, Davis NJ, Marcello RK, Schackman BR, Barron C, Bergmann L. Study protocol for a pragmatic trial of the Consult for Addiction Treatment and Care in Hospitals (CATCH) model for engaging patients in opioid use disorder treatment. Addict Sci Clin Pract. 2019 Feb 19; 14(1):5. PMID: 30777122.

    Read at: PubMed
  • Published on 2/18/2019

    Kathuria H, Seibert RG, Cobb V, Herbst N, Weinstein ZM, Gowarty M, Jhunjhunwala R, Helm ED, Wiener RS. Perceived barriers to quitting cigarettes among hospitalized smokers with substance use disorders: A mixed methods study. Addict Behav. 2019 Aug; 95:41-48. PMID: 30836208.

    Read at: PubMed
  • Published on 7/1/2018

    Weinstein ZM, Wakeman SE, Nolan S. Inpatient Addiction Consult Service: Expertise for Hospitalized Patients with Complex Addiction Problems. Med Clin North Am. 2018 Jul; 102(4):587-601. PMID: 29933817.

    Read at: PubMed
  • Published on 6/19/2018

    Weinstein ZM, Gryczynski G, Cheng DM, Quinn E, Hui D, Kim HW, Labelle C, Samet JH. Tapering off and returning to buprenorphine maintenance in a primary care Office Based Addiction Treatment (OBAT) program. Drug Alcohol Depend. 2018 08 01; 189:166-171. PMID: 29958128.

    Read at: PubMed
  • Published on 12/1/2017

    Mehta AB, Weinstein Z, Walkey AJ. The Untold Toll of the Opioid Crisis on Intensive Care Units in the United States. Ann Am Thorac Soc. 2017 12; 14(12):1763-1765. PMID: 29192818.

    Read at: PubMed
  • Published on 9/9/2017

    Schiff DM, Drainoni ML, Weinstein ZM, Chan L, Bair-Merritt M, Rosenbloom D. A police-led addiction treatment referral program in Gloucester, MA: Implementation and participants' experiences. J Subst Abuse Treat. 2017 Nov; 82:41-47. PMID: 29021114.

    Read at: PubMed
  • Published on 5/16/2017

    Hui D, Weinstein ZM, Cheng DM, Quinn E, Kim H, Labelle C, Samet JH. Very early disengagement and subsequent re-engagement in primary care Office Based Opioid Treatment (OBOT) with buprenorphine. J Subst Abuse Treat. 2017 Aug; 79:12-19. PMID: 28673522.

    Read at: PubMed
  • Published on 5/11/2017

    Trowbridge P, Weinstein ZM, Kerensky T, Roy P, Regan D, Samet JH, Walley AY. Addiction consultation services - Linking hospitalized patients to outpatient addiction treatment. J Subst Abuse Treat. 2017 Aug; 79:1-5. PMID: 28673521.

    Read at: PubMed

View 5 more publications: View full profile at BUMC

View all profiles